Treatment of Pediatric Hypomagnesemia
Magnesium is indicated for treatment of documented hypomagnesemia in pediatric patients, with the route and dosing determined by severity of deficiency and presence of symptoms. 1, 2
Initial Assessment and Diagnosis
Before initiating treatment, establish the diagnosis and severity:
- Hypomagnesemia is defined as serum magnesium <1.8 mg/dL (<0.74 mmol/L), with symptoms typically not appearing until levels fall below 1.2 mg/dL 3
- Check serum magnesium levels in all at-risk pediatric patients, including those with malabsorption, diarrhea, renal disorders, or on medications that increase magnesium losses 4
- Measure fractional excretion of magnesium to determine etiology: values <2% indicate gastrointestinal losses, while >2% suggests renal wasting 3
- Assess renal function before any magnesium supplementation to avoid life-threatening hypermagnesemia 3
Treatment Algorithm Based on Severity
Severe Symptomatic Hypomagnesemia (Serum Mg <1.2 mg/dL with symptoms)
Intravenous magnesium sulfate is required for symptomatic patients with severe deficiency:
- For life-threatening arrhythmias (torsades de pointes): Give 25-50 mg/kg IV (maximum 2 g) as bolus for pulseless torsades, or over 10-20 minutes for torsades with pulses 5
- For severe hypomagnesemia with tetany or seizures: Administer up to 250 mg/kg (approximately 2 mEq/kg) IM within 4 hours if necessary, or 5 g (approximately 40 mEq) added to one liter of IV fluid for slow infusion over 3 hours 2
- Rate of IV injection should generally not exceed 150 mg/minute to avoid hypotension and bradycardia 2
- Monitor continuously for magnesium toxicity: hypotension, bradycardia, respiratory depression, and have calcium chloride available for reversal 5
Moderate Hypomagnesemia (Serum Mg 1.2-1.8 mg/dL, asymptomatic)
Oral magnesium supplementation is appropriate for asymptomatic patients:
- For infants in hyperalimentation: Maintenance dose ranges from 2-10 mEq (0.25-1.25 g) daily 2
- For older children: Start with age-appropriate dosing based on recommended daily allowance (320 mg for females, 420 mg for males) and titrate upward as needed 5
- Administer magnesium at night when intestinal transit is slowest to improve absorption 5
- Use organic magnesium salts (aspartate, citrate, lactate) rather than magnesium oxide for better bioavailability, though magnesium oxide at 12-24 mmol daily is commonly used 5
Critical Precautions and Monitoring
Address underlying causes before supplementation:
- In patients with diarrhea or high gastrointestinal losses, correct sodium and water depletion first to address secondary hyperaldosteronism, which increases renal magnesium wasting 5
- Normalize magnesium levels before attempting to correct concurrent hypokalemia, as magnesium deficiency causes refractory hypokalemia through dysfunction of potassium transport systems 5
- Avoid magnesium supplementation if creatinine clearance <20 mL/min due to high risk of life-threatening hypermagnesemia 5
Monitor for complications:
- Magnesium produces vasodilation and may cause hypotension if administered rapidly 1
- Check serum magnesium, potassium, and calcium levels regularly during treatment 5
- Watch for signs of magnesium toxicity: hypotension, bradycardia, respiratory depression, loss of deep tendon reflexes 5
- In patients receiving continuous renal replacement therapy, use dialysis solutions containing magnesium to prevent ongoing losses 5
Special Considerations
For refractory status asthmaticus: Magnesium sulfate 25-50 mg/kg IV (maximum 2 g) over 15-30 minutes may be beneficial 5
Avoid prolonged continuous maternal administration beyond 5-7 days in pregnancy as this can cause fetal abnormalities 2
Most magnesium salts are poorly absorbed and may worsen diarrhea, so monitor gastrointestinal symptoms and adjust formulation if needed 5
The key pitfall is attempting to correct hypomagnesemia without first addressing volume depletion and hyperaldosteronism in patients with gastrointestinal losses, as ongoing renal wasting will exceed supplementation efforts. 5 Another common error is failing to recognize that hypokalemia will remain refractory until magnesium is normalized. 5